Johnson & Johnson (NYSE: JNJ) is to acquire the remaining stake in Verb Surgical, a Mountain View, CA-based company building a digital surgery platform that combines robotics, advanced visualization, advanced instrumentation, data analytics, and connectivity.
The transaction is expected to close in the first half of 2020, subject to antitrust clearance and customary closing conditions.
The amount of the deal was not disclosed.
Combining robotics, enhanced visualization, advanced instrumentation, machine learning, data analytics and end-to-end connectivity, the acquiring company continues to strengthen its digital surgery portfolio to bring its insights and experience in science, medical technology and digital solutions to medical interventions, including open surgery, laparoscopic, percutaneous and endoluminal procedures.
The acquisition follows a strategic collaboration with Verily, an Alphabet company.